AI for Pharma & Healthcare 2025

Botox-maker Allergan Inc.announced the second-quarter profit early Friday

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Measuring Digital Health Success: KPIs and...

Measuring Success: KPIs and Metrics for Digital Health Initiatives The...

Data-Driven Quality Improvement: Enhancing Patient Outcomes

Data-Driven Quality Improvement: Using Analytics to Enhance Patient Outcomes The...

Connected Health in the US Overcoming...

It is well to be noted that the intersection...

New Plastic Design Prevents Biofilm Formation...

Researchers have found that bacterial cells can be tricked...
Research Insight
Botox-maker Allergan Inc. announced the second-quarter profit early Friday, the figures were substantially higher, attributable in part to the company’s cost-cutting measures.

Botox-maker Allergan Inc. announced the second-quarter profit early Friday, the figures were substantially higher, attributable in part to the company’s cost-cutting measures.

Allergan registered its second-quarter earnings rose to $176.1 million from $143.4 million in the year-earlier period.

Excluding various items, Allergan would have posted adjusted earnings of 75 cents a share compared to the year-earlier 63 cents.

Analysts polled by FactSet were expecting earnings of 67 cents a share, on average.

Revenue for the quarter slipped to $1.13 billion from $1.17 billion. Excluding the impact of a strong U.S. dollar overseas, sales would have been up 2.2%.

The Irvine, Calif.-based company also issued its financial forecast. Allergan now sees adjusted earnings of 67 cents to 69 cents a share for the third quarter and $2.71 to $2.75 a share for the full year.

Full-year sales should come in between $4.2 billion and $4.3 billion, while third-quarter sales are pegged at $1.05 billion to $1.1 billion.

 

Latest stories

Related stories

Measuring Digital Health Success: KPIs and Metrics

Measuring Success: KPIs and Metrics for Digital Health Initiatives The...

Data-Driven Quality Improvement: Enhancing Patient Outcomes

Data-Driven Quality Improvement: Using Analytics to Enhance Patient Outcomes The...

Connected Health in the US Overcoming Health Challenges

It is well to be noted that the intersection...

New Plastic Design Prevents Biofilm Formation on Devices

Researchers have found that bacterial cells can be tricked...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »